BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Long-term Investment Intensity
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Long-term Investment Intensity of 0.1% as of March 2018. Long-term investments of Rs10.50K represent 0.1% of total assets of Rs16.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BALAXI total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BALAXI PHARMACEUTICALS LIMITED Long-term Investment Intensity (2016–2018)
This chart shows how BALAXI PHARMACEUTICALS LIMITED's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of March 2018, the intensity stands at 0.1%, reflecting long-term investments of Rs10.50K against total assets of Rs16.87 Million INR. Also explore BALAXI PHARMACEUTICALS LIMITED asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for BALAXI PHARMACEUTICALS LIMITED (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for BALAXI PHARMACEUTICALS LIMITED from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BALAXI market cap overview.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | Rs10.50K | Rs16.87 Million | ▲ +0.0 pp |
| 2017 | 0.1% | Rs15.00K | Rs25.77 Million | ▼ -9170.1 pp |
| 2016 | 9170.1% | Rs32.74 Million | Rs356.99K | — |